EverSource Wealth Advisors, LLC

Position in ENTA — Enanta Pharmaceuticals Inc

CIK 1710537 BIRMINGHAM, AL

Position in ENTA

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$17,057

+$716 QoQ

Shares Held

1,170

-9.6% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 19 holders

Holding Since

Dec 2021

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

EverSource Wealth Advisors, LLC holds $15,234,841 across 258 Biotechnology names. ENTA ranks #72 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CRSP	CRISPR Therapeutics AG	110,689	$6,036,977
2	INCY	Incyte Corp	9,004	$1,020,689
3	RPRX	Royalty Pharma plc	13,228	$741,689
4	VRTX	Vertex Pharmaceuticals Inc / Ma	1,357	$674,058
5	REGN	Regeneron Pharmaceuticals, Inc.	912	$568,663
6	BEAM	Beam Therapeutics Inc.	16,556	$568,200
7	EXEL	Exelixis, Inc.	8,321	$452,739
8	HALO	Halozyme Therapeutics, Inc.	4,146	$324,502

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$17,057	1,170	-9.6%	Shares	Sole	2026-07-24
2026-03-31	$16,341	1,294	+12.7%	Shares	Sole	2026-05-18
2025-12-31	$18,103	1,148	0.0%	Shares	Sole	2026-02-06
2025-09-30	$13,741	1,148	-0.4%	Shares	Sole	2025-11-10
2025-06-30	$8,716	1,153	+723.6%	Shares	Sole	2025-08-13
2025-03-31	$771	140	+366.7%	Shares	Sole	2025-05-13
2024-12-31	$172	30	-55.9%	Shares	Sole	2025-02-10
2023-06-30	$1,455	68	+78.9%	Shares	Sole	2023-08-04
2022-03-31	$2,704	38	0.0%	Shares	Sole	2022-05-25
2021-12-31	$2,841	38	—	Shares	Sole	2022-02-17
No filing history on record for this holder in this stock.